Remodeling cancer stemness by collagen/fibronectin via the AKT and CDC42 signaling pathway crosstalk in glioma
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (4) , 1991-2005
Abstract
Cancer development is a complex set of proliferative progression, which arises in most cases via multistep pathways associated with various factors, including the tumor microenvironment and extracellular matrix. However, the underlying mechanisms of cancer development remain unclear and this study aimed to explore the role of extracellular matrix in glioma progression.Keywords
This publication has 66 references indexed in Scilit:
- Nestin as a marker of cancer stem cellsCancer Science, 2015
- Cdc42: Role in Cancer ManagementChemical Biology & Drug Design, 2015
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trialThe Lancet Oncology, 2014
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibitionNature Cell Biology, 2014
- Generation of cancer stem-like cells through the formation of polyploid giant cancer cellsOncogene, 2013
- Soft fibrin gels promote selection and growth of tumorigenic cellsNature Materials, 2012
- Role of YAP/TAZ in mechanotransductionNature, 2011
- Collagen type I regulates β-catenin tyrosine phosphorylation and nuclear translocation to promote migration and proliferation of gastric carcinoma cellsOncology Reports, 2010
- Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cellsBritish Journal of Cancer, 2009
- Recombinant Vitronectin Is a Functionally Defined Substrate That Supports Human Embryonic Stem Cell Self-Renewal via αVβ5 IntegrinStem Cells, 2008